NORML | November 15, 2017 PHILADELPHIA, PA — Retail products marketed and sold online as CBD extracts are typically mislabeled with regard to their potency and ingredients, according to findings published in the Journal of the American Medical Association. A research team led by the University of Pennsylvania analyzed the contents of 84 CBD-infused products, produced by 31 different companies. Only 30 percent of the …
FDA Issues Warning To CBD Companies
On November 1st, the U.S. Food and Drug Administration (FDA) published a press release addressing warning letters issued to four companies. The warning letters, sent to companies marketing cannabidiol (CBD) products with therapeutic claims, cites unsubstantiated claims about their products’ ability to treat or cure cancer and other diseases. A snippet of the warning letter issued to Greenroads According to …